CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 134.634
NA - Nord America 7.080
AS - Asia 1.661
SA - Sud America 186
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 143.619
Nazione #
IT - Italia 131.388
US - Stati Uniti d'America 7.025
NL - Olanda 1.065
UA - Ucraina 906
CN - Cina 807
SG - Singapore 641
SE - Svezia 324
DE - Germania 300
FI - Finlandia 287
GB - Regno Unito 180
BR - Brasile 175
FR - Francia 71
IN - India 56
CA - Canada 45
RU - Federazione Russa 33
VN - Vietnam 32
EG - Egitto 22
HK - Hong Kong 19
KR - Corea 17
BE - Belgio 15
ES - Italia 14
IR - Iran 11
AT - Austria 10
PK - Pakistan 9
JP - Giappone 8
MA - Marocco 8
MX - Messico 8
TR - Turchia 8
IE - Irlanda 7
IQ - Iraq 7
UZ - Uzbekistan 7
EU - Europa 6
TW - Taiwan 6
HU - Ungheria 5
IL - Israele 5
PT - Portogallo 5
TH - Thailandia 5
AR - Argentina 4
AU - Australia 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
NG - Nigeria 4
PL - Polonia 4
RS - Serbia 4
ZA - Sudafrica 4
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
ID - Indonesia 2
KZ - Kazakistan 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
CO - Colombia 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 143.619
Città #
Cagliari 128.494
Uta 2.458
Amsterdam 1.051
Woodbridge 892
Fairfield 742
Chandler 538
Houston 534
Jacksonville 516
Wilmington 430
Ann Arbor 416
Ashburn 415
Boardman 391
Seattle 299
Cambridge 281
Singapore 250
Nyköping 247
Dearborn 154
Helsinki 153
Nanjing 148
Beijing 120
Boston 116
Munich 81
Santa Clara 78
Shanghai 68
Nanchang 61
New York 56
Shenyang 50
Milan 48
Hebei 46
San Diego 44
Verona 40
Jiaxing 39
Redwood City 34
Dong Ket 32
Tianjin 32
Toronto 32
Changsha 31
Guangzhou 31
Mountain View 29
Auburn Hills 23
Los Angeles 23
Norwalk 23
Olbia 23
Orange 21
Washington 20
Hefei 18
Atlanta 16
Zhengzhou 16
Jinan 15
Selargius 15
Ferrara 14
Sassari 14
Falls Church 13
Hangzhou 12
São Paulo 12
Belo Horizonte 11
Brussels 11
London 11
Ningbo 11
Rome 11
Nuremberg 10
Perugia 10
Phoenix 10
Wuhan 10
Cairo 9
Kunming 9
Chapel Hill 8
Council Bluffs 8
Indiana 8
Messina 8
Monserrato 8
Banha 7
Central 7
Champaign 7
Hong Kong 6
Tappahannock 6
Weihai 6
Brasília 5
Budapest 5
Dublin 5
Fuzhou 5
Jyväskylä 5
Mainz 5
Quartu Sant'elena 5
Rawalpindi 5
Redmond 5
San Francisco 5
Taizhou 5
Tashkent 5
Vienna 5
Altofonte 4
Baku 4
Bangkok 4
Barcelona 4
Belgrade 4
Chennai 4
Columbus 4
Costa Mesa 4
Gangnam-gu 4
Goiânia 4
Totale 140.052
Nome #
Synthesis and antiproliferative activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on human cancer cell lines 12.441
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 6.564
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 4.858
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.550
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.765
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.649
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.643
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.579
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.520
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.465
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.458
Critical role for prokineticin 2 in CNS autoimmunity 2.372
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.295
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 2.292
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.288
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.191
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity 2.177
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 2.113
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.057
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 2.056
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 1.983
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.954
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.921
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.823
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.790
null 1.768
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives 1.763
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.756
An important role for prokineticin 2 in autoimmune CNS demyelination 1.742
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.738
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 1.718
null 1.650
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.381
DESIGN, SYNTHESIS, AND EVALUATION OF (ISO)NIPECOTAMIDE AND PIPERAZINYLUREA DERIVATIVES AS TRPV1 MODULATORS 1.318
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.301
null 1.242
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.203
New trifluoromethylated pyridines from functionalized N-1-acylacetamidrazones 1.195
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.167
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.126
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 1.034
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 856
null 825
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 793
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 784
Reactivity of N1-Acylacetamidrazones towards Diethyl Acetylenedicarboxylate: Cyclization to Ethyl Pyrroleacetates and 1-Acylaminopyridones 759
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 737
null 731
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives 705
null 670
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 670
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 659
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 659
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 652
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 616
null 613
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 588
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 579
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 551
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 513
Synthesis and structural studies of 3-acylamino-4-amino-2,3-dihydro-2-iminothiazole-5-carboxylates and 4-acylhydrazino-2-aminothiazole-5-carboxylates 497
Synthesis and antimicrobial activity of some pyrrole derivatives 470
null 466
null 457
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 455
null 424
null 416
null 414
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 408
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 399
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 388
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides 388
Attività antimicrobica di derivati pirrolici 384
null 378
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 376
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 364
null 361
null 350
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 349
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 348
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 345
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 341
null 341
null 341
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 340
Design, synthesis and pharmacological investigation on new FAAH inhibitors 339
Design, Synthesis, Biological Activity and SAR of New FAAH Inhibitors 338
null 332
Synergistic activity between rifamycins and a new class of isothiosemicarbazones against Mycobacterium avium 328
null 327
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives 327
Synthesis and antimycobacterial activity of new S-alkylisotiosemicarbazone derivatives 320
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis 316
null 311
Attività Antimicobatterica di Nuovi S-alchilisotiosemicarbazoni e Potenziamento dell’Attività di Rifampicina e Rifabutina nei Confronti di M. Avium 303
Synthesis and Antitubercular activity of N1-Isonicotinoylamidrazones Derivatives 299
Synergistic Activity between Rifamycins and a New Class of Isothiosemicarbazones against Mycobacterium avium 298
null 296
Synthesis and antimicrobial activity of some pyrrole derivatives. II: 2-(2'-acylhydrazino)-3-ethoxycarbonyl-5-aryl (or alkyl)- pyrrole derivatives 295
null 294
Totale 126.389
Categoria #
all - tutte 179.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.178 0 0 0 0 0 0 0 0 0 480 461 1.237
2020/202125.043 1.013 613 1.195 6.058 5.112 3.079 2.556 1.504 513 1.106 1.192 1.102
2021/20224.171 381 345 336 236 225 315 313 293 281 470 353 623
2022/20237.334 730 726 657 519 535 908 490 1.070 467 345 575 312
2023/20249.379 422 365 449 713 975 1.628 1.563 546 446 645 743 884
2024/202554.778 20.762 13.225 13.053 2.052 1.635 1.129 1.205 155 327 1.235 0 0
Totale 143.943